CompletedNot Applicable

Study of Peripheral Blood Non-coding RNAs as Diagnosis and Prognosis Biomarker for Acute Pancreatitis

China1,097 participantsStarted 2015-12

Plain-language summary

It is important to identify patients with acute pancreatitis who are at risk for developing persistent organ failure early in the course of disease. The investigators evaluated whether peripheral blood non-coding RNAs, including microRNAs and long noncoding RNA (lncRNA), could serve as a good marker for detection of acute pancreatitis with persistent organ failure at early phase.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who was diagnosed acute pancreatitis * Male or female * 18 Years and older * written informed consent Exclusion Criteria: * Symptoms of acute pancreatitis present for more than 72 hours * Age under 18 years * Pregnancy * patients unable to consent

What they're measuring

The level of non-coding RNAs in peripheral blood

Timeframe: At admission

Trial details

NCT IDNCT02602808

SponsorChanghai Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12

View on ClinicalTrials.gov More Acute Pancreatitis trials